Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of antibodies for enrichment of engineered T cells with exogenous immune receptors and antibodies for use in depletion of engineered T cells

Use of antibodies for enrichment of engineered T cells with exogenous immune receptors and antibodies for use in depletion of engineered T cells

US Patent 10973895 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of cell therapy2025
Compositions and methods for cell targeting therapies2024
Compositions comprising gamma 9 delta 2 T-cell receptors and methods of use ther2023
Human leukocyte antigen restricted gamma delta T cell receptors and methods of u2023
Method for identifying δT-cell (or γT-cell) receptor chains or parts thereof tha2021
Nucleic acid molecules encoding combinatorial gamma 9 delta 2 T-cell receptors a2020
Methods of treating cancer in a subject by administering a composition comprisin2019
Gamma 9 delta 2 T cell receptors2018